Avandia and Heart Attacks (Cont.)

FDA Recommendations for Avandia and Heart Attacks

The U.S. Food and Drug Administration (FDA) has issued a report on this subject. The FDA has not confirmed that the risk is "clinically significant." The FDA also reminds healthcare providers and patients that several other studies contradict the study in question. The FDA has been examining this issue and will continue to do so. At this time, the FDA does not suggest that Avandia should be removed from the market, but does recommend that people taking Avandia discuss the issue with their healthcare providers.
 
Because stopping or switching any diabetes medication can be dangerous, it is important to carefully weigh the risks and benefits of Avandia with your healthcare provider. Do not stop taking Avandia without first discussing it with your healthcare provider. Additional analysis may suggest that Avandia does indeed increase the risk of heart attacks. Until then, further research is needed to fully understand the risks associated with Avandia.
Pages:

Previous 1   2   3

Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;